Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
€ 197,60 ↓ -1.70 (-0.85%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership20,758 shares
Latest Disclosed Value $ 3,508,517
Millennium Management Llc ownership in 19X / Axsome Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 20,758 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $2,912,347 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 33,937 shares of Axsome Therapeutics, Inc.. This represents a change in shares of -38.83% during the quarter. The current value of the position is $4,101,781 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (19X) in the form of stock options. The firm currently holds call options representing 30,100 of underlying shares valued at $5,087,502 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:19X / Axsome Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 20,758 -13,179 -38.83 3,509 -43.40 0.0015
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 33,937 28,196 491.13 6,198 789.24 0.0026
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 5,741 -24,878 -81.25 697 -78.19 0.0003
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 30,619 -204,692 -86.99 3,196 -88.35 0.0015
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 235,311 231,065 5,441.95 27,444 7,544.57 0.0146
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 4,246 -20,508 -82.85 359 -83.86 0.0002
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 24,754 -715,065 -96.65 2,225 -96.27 0.0011
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 739,819 -1,699 -0.23 59,555 0.65 0.0276
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 741,518 -168,447 -18.51 59,173 -18.30 0.0253
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 909,965 406,923 80.89 72,424 106.00 0.0313
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 503,042 -232,061 -31.57 35,158 -33.45 0.0177
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 735,103 -304,264 -29.27 52,825 -17.60 0.0260
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 1,039,367 1,039,367 64,108 0.0368
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -351,140 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 351,140 3,689 1.06 15,668 17.74 0.0093
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 347,451 329,798 1,868.23 13,307 1,720.38 0.0083
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 17,653 -68,006 -79.39 731 -77.41 0.0004
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 85,659 -51,666 -37.62 3,236 -28.50 0.0016
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 137,325 -79,514 -36.67 4,526 -69.06 0.0027
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 216,839 -19,324 -8.18 14,628 9.39 0.0090
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 236,163 87,205 58.54 13,372 10.18 0.0096
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 148,958 46,639 45.58 12,136 66.47 0.0088
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 102,319 -54,935 -34.93 7,290 -43.66 0.0090
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 157,254 4,923 3.23 12,939 44.38 0.0177
2020-05-14 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 152,331 -352,407 -69.82 8,962 -82.82 0.0201
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 504,738 108,438 27.36 52,170 550.42 0.0653
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 396,300 6,784 1.74 8,021 -20.03 0.0127
2019-08-15 2019-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 389,516 -374,458 -49.01 10,030 -7.74 0.0151
2019-08-14 2019-06-30 13F AZUL S A SPONSR ADR PFD 05464T104 1,061,345 297,371 35,491
2019-05-14 2019-03-31 13F AXSOME THERAPEUTICS COM 05464T104 763,974 455,172 147.40 10,871 1,148.11 0.0163
2019-02-15 2018-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 308,802 308,802 871 0.0014
2019-02-14 2018-12-31 13F AXSOME THERAPEUTICS COM 05464T104 308,802 871
2018-05-15 2018-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -125,906 -100.00 0 -100.00
2018-02-14 2017-12-31 13F AXSOME THERAPEUTICS COM 05464T104 125,906 -44,152 -25.96 705 -25.32 0.0010
2017-11-14 2017-09-30 13F AXSOME THERAPEUTICS COM 05464T104 170,058 10,098 6.31 944 7.27 0.0014
2017-08-14 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 159,960 78,984 97.54 880 178.48 0.0016
2017-05-15 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 80,976 -3,829 -4.52 316 -44.76 0.0006
2017-02-14 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 84,805 84,805 0.00 572 0.0012
2016-05-16 2016-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -55,809 -100.00 0 -100.00
2016-02-16 2015-12-31 13F AXSOME THERAPEUTICS COM 05464T104 55,809 55,809 517 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM Call 30,100 5,088 n/a n/a n/a
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Call 25,200 98.43 2,939 173.65 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Call 12,700 1,075 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM Call 3,800 -86.52 266 -86.92 n/a n/a n/a
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM Call 28,200 2,026 n/a n/a n/a
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM Call 375,000 14,362 n/a n/a n/a
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM Call 40,000 300.00 1,511 357.88 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM Call 10,000 330 n/a n/a n/a
2020-05-14 2020-03-31 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM Call 50,000 5,168 n/a n/a n/a
2019-08-15 2019-06-30 13F/A AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F AXSOME THERAPEUTICS COM Call 20,000 285 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Put 118,800 266.67 10,052 245.28 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Put 32,400 2,912 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Put 12,100 -42.92 966 -42.80 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Put 21,200 430.00 1,687 504.66 n/a n/a n/a
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM Put 4,000 -4.76 280 -7.31 n/a n/a n/a
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM Put 4,200 302 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM Put 293,900 9,687 n/a n/a n/a
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM Put 25,000 177.78 1,416 93.18 n/a n/a n/a
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM Put 9,000 733 n/a n/a n/a
2020-05-14 2020-03-31 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM Put 50,000 5,168 n/a n/a n/a
2019-08-15 2019-06-30 13F/A AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F AXSOME THERAPEUTICS COM Put 179,500 2,554 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.